Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?

Clinical and Applied Thrombosis/Hemostasis

Saved in:

Bibliographic Details
Main Authors:	Koh, S.C.L., Tham, K.-F., Razvi, K., Oei, P.-L., Lim, F.-K., Roy, A.-C., Prasad, R.N.V.
Other Authors:	OBSTETRICS & GYNAECOLOGY
Format:	Article
Published:	2013
Subjects:	Fibrinolytic Hemostatic Ovarian cancer
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/36683
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-36683
record_format	dspace
spelling	sg-nus-scholar.10635-366832015-01-07T22:07:17Z Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome? Koh, S.C.L. Tham, K.-F. Razvi, K. Oei, P.-L. Lim, F.-K. Roy, A.-C. Prasad, R.N.V. OBSTETRICS & GYNAECOLOGY Fibrinolytic Hemostatic Ovarian cancer Clinical and Applied Thrombosis/Hemostasis 7 2 141-148 CATHF 2013-04-10T02:54:45Z 2013-04-10T02:54:45Z 2001 Article Koh, S.C.L.,Tham, K.-F.,Razvi, K.,Oei, P.-L.,Lim, F.-K.,Roy, A.-C.,Prasad, R.N.V. (2001). Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?. Clinical and Applied Thrombosis/Hemostasis 7 (2) : 141-148. ScholarBank@NUS Repository. 10760296 http://scholarbank.nus.edu.sg/handle/10635/36683 NOT_IN_WOS Scopus
institution	National University of Singapore
building	NUS Library
country	Singapore
collection	ScholarBank@NUS
topic	Fibrinolytic Hemostatic Ovarian cancer
spellingShingle	Fibrinolytic Hemostatic Ovarian cancer Koh, S.C.L. Tham, K.-F. Razvi, K. Oei, P.-L. Lim, F.-K. Roy, A.-C. Prasad, R.N.V. Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?
description	Clinical and Applied Thrombosis/Hemostasis
author2	OBSTETRICS & GYNAECOLOGY
author_facet	OBSTETRICS & GYNAECOLOGY Koh, S.C.L. Tham, K.-F. Razvi, K. Oei, P.-L. Lim, F.-K. Roy, A.-C. Prasad, R.N.V.
format	Article
author	Koh, S.C.L. Tham, K.-F. Razvi, K. Oei, P.-L. Lim, F.-K. Roy, A.-C. Prasad, R.N.V.
author_sort	Koh, S.C.L.
title	Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?
title_short	Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?
title_full	Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?
title_fullStr	Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?
title_full_unstemmed	Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?
title_sort	hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: could d-dimer and antithrombin iii levels be included as prognostic markers for survival outcome?
publishDate	2013
url	http://scholarbank.nus.edu.sg/handle/10635/36683
_version_	1681081691648557056

Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?

Similar Items